세계의 전혈구계산 기기 시장 보고서(2025년)
Complete Blood Count Device Global Market Report 2025
상품코드 : 1760509
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 175 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,487,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,376,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,266,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

전혈구계산 기기 시장 규모는 향후 몇 년 동안 강력한 성장세를 보일 것으로 예상되며, 2029년에는 6.0%의 CAGR로 55억 1,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안 성장의 원동력은 혈액 분석기의 기술 발전, 진단 프로세스에 AI 및 자동화 도입, 현장 검사 수요 증가, 신흥 시장의 의료비 지출 증가, 만성질환 유병률 증가 등입니다. 이 기간 동안 주요 동향으로는 결과 해석에 AI 사용, 현장 진료용 기기의 소형화, 무선 데이터 전송 기능, 카트리지형 소모품 개발, 다중 검사 기능 추가 등을 꼽을 수 있습니다.

혈액 질환의 유병률 증가는 향후 몇 년 동안 전혈구계산 기기 시장의 성장을 촉진할 것으로 예상됩니다. 혈액질환은 혈액세포의 생산, 기능, 구조에 영향을 미쳐 혈액 기능에 장애를 초래하는 상태를 말합니다. 혈액질환의 증가는 생활습관병의 유병률 증가와 관련이 있으며, 식습관 장애, 운동 부족, 스트레스 등이 빈혈, 혈액응고장애 등의 증상에 영향을 미치고 있습니다. 전혈구계산(CBC) 기기는 주요 혈액 성분을 분석하고 이상을 식별하여 혈액 질환의 진단을 돕고, 의료 전문가가 응고 장애를 발견하고 적시에 정확한 치료를 제공할 수 있도록 돕습니다. 예를 들어, 2024년 5월 캐나다에 기반을 둔 단체인 캐나다 암 협회는 4,100명이 다발성 골수종(혈액암의 일종) 진단을 받았고, 1,750명이 이 질병으로 사망했다고 보고했습니다. 따라서 혈액 질환의 유병률 증가는 전혈구계산 기기 시장의 성장을 촉진하고 있습니다.

전혈구계산 기기 시장의 주요 기업들은 보다 정확하고 신속하며 비용 효율적인 현장 검사 솔루션을 제공하기 위해 소형 혈액 분석기와 같은 첨단 제품을 개발하고 있습니다. 소형 혈액 분석기는 휴대가 가능하고 사용자 친화적인 장치로 최소한의 샘플로 빠르고 정확한 전혈구계산(CBC) 결과를 제공하기 때문에 현장 진료 시 사용하기에 적합합니다. 이 기기들은 진단 정확도, 효율성, 사용 편의성을 향상시키며, 합리적인 가격과 유지보수가 용이합니다. 예를 들어, 2024년 6월 일본의 분석 및 측정 기술 기업 호리바(HORIBA)는 Yumizen H550E 및 H500E 혈액 분석기를 출시했습니다. 이 소형 분석기는 적혈구 침강속도(ESR) 검사와 전혈구계산(CBC) 및 5분획식(DIFF) 분석을 결합한 것으로, 호리바의 특허 기술인 CoRA(Correlation Rouleau Analysis)를 사용하여 전혈 검체에서 단 60초 만에 종합적인 결과를 얻을 수 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별·국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

제31장 기타 주요 기업과 혁신적 기업

제32장 세계의 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병

제34장 최근의 시장 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

제36장 부록

ksm
영문 목차

영문목차

A complete blood count (CBC) device is a medical tool used to conduct a complete blood count, a common laboratory test that measures the levels and characteristics of different blood components. This device automates the blood analysis process, providing accurate and quick results that help healthcare professionals make informed diagnostic and treatment decisions.

The main categories of complete blood count devices include automated blood count analyzers, manual blood count analyzers, point-of-care testing devices, and hematology analyzers. Automated blood count analyzers are sophisticated instruments that utilize various technologies to quickly and precisely count and classify blood cells, improving efficiency and minimizing manual errors in clinical laboratories. These devices perform tests such as white blood cell (WBC) count, WBC differential count, red blood cell (RBC) count, hematocrit (HCT), hemoglobin (HGB), platelet count, mean platelet volume (MPV), mean corpuscular hemoglobin (MCH), and others. They employ technologies like impedance, laser-based methods, flow cytometry, and microscopy. Distribution occurs through channels such as direct sales, online platforms, third-party distributors, and retail pharmacies, with end-users including hospitals, diagnostic labs, research centers, and more.

The complete blood count devices market research report is one of a series of new reports from The Business Research Company that provides complete blood count devices market statistics, including the complete blood count devices industry global market size, regional shares, competitors with the complete blood count devices market share, detailed complete blood count devices market segments, market trends, opportunities, and any further data you may need to thrive in the complete blood count devices industry. This complete blood count devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The complete blood count device market size has grown strongly in recent years. It will grow from $4.11 billion in 2024 to $4.36 billion in 2025 at a compound annual growth rate (CAGR) of 6.2%. The growth during the historic period can be attributed to an increasing incidence of infectious diseases, heightened awareness of preventive healthcare, expansion of diagnostic laboratories, growth in public health screening initiatives, and a rising elderly population.

The complete blood count device market size is expected to see strong growth in the next few years. It will grow to $5.51 billion in 2029 at a compound annual growth rate (CAGR) of 6.0%. The projected growth in the forecast period is driven by technological advancements in hematology analyzers, the incorporation of AI and automation in diagnostic processes, increasing demand for point-of-care testing, rising healthcare spending in emerging markets, and the growing prevalence of chronic diseases. Key trends during this time include the use of AI for interpreting results, miniaturization of devices for point-of-care applications, wireless data transmission capabilities, development of cartridge-based consumables, and the addition of multiplex testing functionalities.

The increasing prevalence of blood disorders is expected to drive the growth of the complete blood count device market in the coming years. Blood disorders are conditions that affect the production, function, or structure of blood cells, leading to impaired blood function. The rise in blood disorders is associated with the growing incidence of lifestyle-related diseases, where poor diet, lack of physical activity, and stress contribute to conditions such as anemia and clotting problems. Complete blood count (CBC) devices assist in diagnosing blood disorders by analyzing key blood components and identifying abnormalities, enabling healthcare professionals to detect clotting disorders and provide timely, accurate treatment. For example, in May 2024, the Canadian Cancer Society, a Canada-based organization, reported that 4,100 individuals were diagnosed with multiple myeloma (a type of blood cancer), while 1,750 died from the disease. Therefore, the rising prevalence of blood disorders is fueling the growth of the complete blood count device market.

Leading companies in the complete blood count device market are developing advanced products such as compact hematology analyzers to offer more accurate, faster, and cost-effective solutions for point-of-care testing. Compact hematology analyzers are portable and user-friendly devices that deliver rapid, precise complete blood count (CBC) results with minimal sample volume, making them ideal for use at the point of care. These devices improve diagnostic accuracy, efficiency, and ease of use while being affordable and easy to maintain. For instance, in June 2024, HORIBA, a Japan-based analytical and measurement technology company, launched the Yumizen H550E and H500E hematology analyzers. These compact analyzers combine erythrocyte sedimentation rate (ESR) testing with complete blood count (CBC) and 5-part differential (DIFF) analysis, using HORIBA's patented CoRA (correlated rouleaux analysis) technology to deliver comprehensive results from whole blood samples in just 60 seconds.

In February 2024, Sysmex Corporation, a Japan-based hematology analyzer manufacturer, partnered with CellaVision AB to advance hematology through innovations in digital cell morphology. The collaboration seeks to improve efficiency, precision, and standardization in hematology testing by integrating Sysmex's hematology expertise with CellaVision's AI-powered imaging technologies, allowing for more accurate diagnoses and better clinical outcomes. CellaVision AB is a Sweden-based provider of digital hematology microscopy solutions.

Major players in the complete blood count device market are Abbott Laboratories, Siemens Healthineers, Mindray Medical International Limited, Beckman Coulter Inc., Bio-Rad Laboratories, Sysmex Corporation, Horiba Ltd., Nihon Kohden Corporation, Agappe Diagnostics Ltd., Trivitron Healthcare Pvt. Ltd., HemoCue AB, EKF Diagnostics Holdings plc, Erba Mannheim, Boule Diagnostics AB, Biosystems S.A., Diatron MI Zrt., Ajanta Export Industries, Labtron Equipment Ltd., Microlab Instruments Co. Pvt. Ltd., URIT Medical Electronic Co. Ltd.

North America was the largest region in the complete blood count device market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in complete blood count (CBC) device report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the complete blood count (CBC) device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The complete blood count (CBC) device market consists of sales of automated hematology analyzers, point-of-care CBC devices, reagents and consumables. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Complete Blood Count Device Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on complete blood count device market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for complete blood count device ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The complete blood count device market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Complete Blood Count Device Market Characteristics

3. Complete Blood Count Device Market Trends And Strategies

4. Complete Blood Count Device Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Complete Blood Count Device Growth Analysis And Strategic Analysis Framework

6. Complete Blood Count Device Market Segmentation

7. Complete Blood Count Device Market Regional And Country Analysis

8. Asia-Pacific Complete Blood Count Device Market

9. China Complete Blood Count Device Market

10. India Complete Blood Count Device Market

11. Japan Complete Blood Count Device Market

12. Australia Complete Blood Count Device Market

13. Indonesia Complete Blood Count Device Market

14. South Korea Complete Blood Count Device Market

15. Western Europe Complete Blood Count Device Market

16. UK Complete Blood Count Device Market

17. Germany Complete Blood Count Device Market

18. France Complete Blood Count Device Market

19. Italy Complete Blood Count Device Market

20. Spain Complete Blood Count Device Market

21. Eastern Europe Complete Blood Count Device Market

22. Russia Complete Blood Count Device Market

23. North America Complete Blood Count Device Market

24. USA Complete Blood Count Device Market

25. Canada Complete Blood Count Device Market

26. South America Complete Blood Count Device Market

27. Brazil Complete Blood Count Device Market

28. Middle East Complete Blood Count Device Market

29. Africa Complete Blood Count Device Market

30. Complete Blood Count Device Market Competitive Landscape And Company Profiles

31. Complete Blood Count Device Market Other Major And Innovative Companies

32. Global Complete Blood Count Device Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Complete Blood Count Device Market

34. Recent Developments In The Complete Blood Count Device Market

35. Complete Blood Count Device Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기